About Familial Hypercholesterolemia
Familial hypercholesterolemia (FH) is a genetic disorder characterized by significantly elevated levels of low-density lipoprotein cholesterol (LDL-C), leading to increased atherogenesis and early cardiovascular disease. FH is primarily caused by autosomal dominant mutations in three genes: LDL receptor (LDLR), apolipoprotein B (APOB), and proprotein convertase subtilisin/kexin type 9 (PCSK9). These mutations impair the clearance of LDL-C from the bloodstream, resulting in its accumulation.
The non-modifiable risk factors of FH are factors that cannot be changed. These include:
- Genetic predisposition: Being born to parents who carry the FH gene mutation increases the risk of developing homozygous FH.
The modifiable risk factors of FH are factors that can be influenced or changed. Since FH is a genetic condition, there are no modifiable risk factors for the disease. However, there are certain factors that can make the condition worse or increase the risk of complications:
- Lifestyle factors: Unhealthy lifestyle choices, such as a diet high in saturated fats, lack of physical activity, smoking, and obesity, can worsen the risk profile for cardiovascular disease in individuals with FH.
- Metabolic and endocrine disorders: Conditions like diabetes, hypertension, and certain endocrine disorders (e.g., thyroid disorders or polycystic ovary syndrome) can increase the risk of cardiovascular disease in FH patients.
It's important to note that while lifestyle modifications can help manage cholesterol levels, medication is usually necessary for effective treatment. Consult with your healthcare professional for personalized advice.
Familial hypercholesterolemia (FH) is a genetic disorder characterized by elevated levels of LDL cholesterol in the blood. The symptoms of FH can vary depending on the severity and progression of the condition. Common early signs and symptoms of FH include:
- Elevated LDL cholesterol levels
- Cholesterol deposits called xanthomas (bumps around the knees, knuckles, or elbows)
Other common symptoms in later stages or higher severity of FH include:
- Chest pain or discomfort
- Peripheral vascular disease
- Stroke
- Aortic aneurysm
- Cholesterol deposits around the inner edge of the cornea
It's important to note that not everyone with FH will experience all these symptoms, and some individuals may not have any symptoms at all. If you suspect you have FH or have concerns about your cholesterol levels, it's important to consult with your healthcare professional for proper diagnosis and management.
To diagnose familial hypercholesterolemia (FH), the following examinations, tests, and procedures are commonly performed:
- Physical exam: A healthcare provider will conduct a physical exam to look for physical signs of a medical problem, such as pain, swelling, or the presence of masses within the body.
- Lab tests: Blood tests may be ordered to check lipid levels, including total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. These tests help diagnose FH and assess its severity.
- Family history evaluation: A thorough evaluation of family history is essential as FH is an inherited condition. Identifying a family history of high cholesterol or premature heart disease can aid in diagnosing FH.
- Genetic testing: Genetic testing can identify specific gene mutations associated with FH. This test helps confirm the diagnosis and determine if FH is inherited.
To determine the stage or severity of FH, additional examinations, tests, and procedures may include:
- Imaging studies: Imaging studies such as X-rays or MRIs may be recommended to assess the extent of plaque buildup in the arteries and check for any other cardiovascular abnormalities.
- Cardiac stress test: This test evaluates how well your heart functions during physical activity and can help assess the risk of heart disease in individuals with FH.
- Coronary angiography: In some cases, a coronary angiography may be performed to visualize the blood vessels supplying the heart and identify any blockages or narrowing caused by plaque buildup.
It's important to consult with your healthcare provider who can recommend specific examinations, tests, and procedures based on your individual situation.
The goals of treatment for familial hypercholesterolemia (FH) are to control lipid levels in the blood and prevent the development of atherosclerotic cardiovascular disease. The following medications, therapies, health behavior changes, and other treatments are recommended to achieve these treatment goals:
Medications:
- Statins: These drugs are the first-line therapy for FH and work by inhibiting an enzyme involved in cholesterol production, thereby lowering LDL cholesterol levels.
- Ezetimibe: This medication reduces the absorption of cholesterol from the diet and can be used in combination with statins to further lower LDL cholesterol levels.
- Monoclonal Antibodies: These novel drugs inhibit enzymes or proteins involved in regulating LDL cholesterol levels.
Health behavior changes:
- Maintaining a healthy weight
- Exercising regularly
- Quitting smoking
- Limiting alcohol consumption
Other treatments:
- Emerging therapies: Several novel treatments are being studied for FH management, such as inhibitors of angiopoietin-like protein 3 (ANGPLT3). These therapies aim to further lower LDL cholesterol levels.
It's important to note that specific treatment plans may vary depending on the severity of FH and individual patient factors. Treatment of FH often requires more than one therapeutic approach. Consult with a healthcare professional for personalized recommendations. Medication dosing may be affected by many factors. Check with your health care professional about dosing for your individual situation. Other side effects can occur. Check with your health care professional or read the information provided with your medication for additional side effect information.